Search
for

    Sort by

    Research 31–60 of 1000+

    1. 724 - A phase 2b, randomized, double-blinded, parallel-group, placebo-controlled study to evaluate the efficacy and safety of rezpegaldesleukin in adults with severe to very-severe alopecia areata British Journal of Dermatology · 2024
    2. Current Treatments for Alopecia Areata 2015 · 21 citations
    3. 33774 Baricitinib results in eyebrow and eyelash growth in patients with alopecia areata who do not achieve 20% or less scalp hair loss Journal of The American Academy of Dermatology · 2022 · 1 citations
    4. Abrocitinib Treatment in Diffuse Alopecia Areata: A Case Report and a Literature Review Clinical Case Reports · 2026
    5. Reporte de caso: alopecia areata universal tratada exitosamente con baricitinib 2024
    6. Significant improvement with ivarmacitinib after suboptimal response to tofacitinib in severe alopecia areata: a case report and literature review Frontiers in Immunology · 2026
    7. Treatment of Lichen Planopilaris With Abrocitinib International Journal of Dermatology · 2025 · 1 citations
    8. Treatment of concomitant alopecia areata and systemic lupus erythematosus with ivarmacitinib: a case report and literature review Frontiers in Medicine · 2026
    9. Upadacitinib in the treatment of a patient with the triad of atopic dermatitis, vitiligo, and alopecia areata: a case report and literature review Frontiers in Immunology · 2026
    10. Upadacitinib for management of alopecia areata and rheumatoid arthritis: Letter to the editor JEADV clinical practice · 2024
    11. Upadacitinib Efficacy for the Treatment of Concomitant Psoriasis and Alopecia Areata 2023
    12. Low-dose tofacitinib for treating patients with severe alopecia areata: an efficient and cost-saving regimen European Journal of Dermatology · 2019 · 15 citations
    13. P64 Efficacy of baricitinib in patients with different degrees of severe alopecia areata: 52-week results from BRAVE-AA1 and BRAVE-AA2 British Journal of Dermatology · 2023
    14. Concomitant management of alopecia universalis and ulcerative colitis with upadacitinib Internal Medicine Journal · 2024 · 2 citations
    15. Excellent response to tofacitinib treatment in a patient with alopecia universalis Acta dermatovenerologica Alpina, Pannonica et Adriatica (Tiskana izd.) · 2017 · 16 citations
    16. Successful treatment of coexisting alopecia areata and hidradenitis suppurativa with upadacitinib Anais Brasileiros de Dermatologia · 2026
    17. The role of janus kinases in the treatment of autoimmune skin diseases Farmacja Polska · 2021 · 1 citations
    18. JAK1 Signaling Is Involved in the Induction of Mechanical Alloknesis in Atopic Dermatitis Biomedicines · 2025
    19. Successful hair regrowth in a Korean patient with alopecia universalis following tofacitinib treatment Singapore Medical Journal · 2017 · 8 citations
    20. Good efficacy achieved by baricitinib in the treatment of anti-MDA5 antibody-positive dermatomyositis with alopecia areata Rheumatology · 2022 · 3 citations
    21. Survey of pediatric dermatologist views on treatment for alopecia areata JAAD international · 2023
    22. Drug news and therapeutic news Fundamental & clinical pharmacology · 2023
    23. Alopecia areata: Animal models illuminate autoimmune pathogenesis and novel immunotherapeutic strategies Autoimmunity reviews · 2016 · 82 citations
    24. 33766 Efficacy of baricitinib in patients with various degrees of alopecia areata severity: Results from BRAVE-AA1 and BRAVE-AA2 Journal of The American Academy of Dermatology · 2022 · 4 citations
    25. Evaluating the Therapeutic Potential of Ritlecitinib for the Treatment of Alopecia Areata Drug Design Development and Therapy · 2022 · 49 citations
    26. Upadacitinib for the Management of Alopecia Totalis and Subtotalis in Pediatric Patients: A Case Series Reports — Medical Cases Images and Videos · 2026
    27. USE OF UPADACITINIB IN 2 CASES OF REFRACTORY SYSTEMIC LUPUS ERYTHEMATOSUS The Journal of Rheumatology · 2025 · 1 citations
    28. Case report: Psoriasiform eczema with immune-mediated comorbidities treated with upadacitinib Frontiers in Immunology · 2024 · 5 citations
    29. A retrospective analysis of disease epidemiology, comorbidities, treatment patterns, and healthcare resource utilization of alopecia areata in the United Arab Emirates using claims database The Journal of Dermatology · 2024 · 4 citations
    30. Off-label use of biologics and janus kinase (JAK) inhibitors for scarring alopecias: a narrative review Archives of Dermatological Research · 2025 · 3 citations